TY  - JOUR
AU  - Miljković, Nenad
AU  - Godman, Brian
AU  - Kovačević, Milena
AU  - Polidori, Piera
AU  - Tzimis, Leonidas
AU  - Hoppe-Tichy, Torsten
AU  - Saar, Marika
AU  - Antofie, Ioan
AU  - Horvath, Laszlo
AU  - De Rijdt, Thomas
AU  - Vida, Róbert György
AU  - Kkolou, Elena
AU  - Preece, David
AU  - Tubić, Biljana
AU  - Peppard, Joan
AU  - Martinez, Alicia
AU  - Yubero, Cristina Garcia
AU  - Haddad, Ratiba
AU  - Rajinac, Dragana
AU  - Zelić, Pavle
AU  - Jenzer, Helena
AU  - Tartar, Franci
AU  - Gitler, Gunda
AU  - Jeske, Martina
AU  - Davidescu, Michal
AU  - Beraud, Michal
AU  - Kuruc-Poje, Darija
AU  - Haag, Sakstrup Haag
AU  - Fischer, Hanne
AU  - Sviestina, Inese
AU  - Ljubojević, Gordana
AU  - Markestad, Anne
AU  - Vujić-Aleksić, Vesna
AU  - Nežić, Lana
AU  - Crkvenčić, Anica
AU  - Linnolahti, Johanna
AU  - Ašanin, Bogdan
AU  - Duborija-Kovačević, Nataša
AU  - Bochenek, Tomasz
AU  - Huys, Isabelle
AU  - Miljković, Branislava
PY  - 2020
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/3586
AB  - Introduction: While medicine shortages are complex, their mitigation is more of a challenge. Prospective risk assessment as a means to mitigate possible shortages, has yet to be applied equally across healthcare settings. The aims of this study have been to: 1) gain insight into risk-prevention against possible medicine shortages among healthcare experts; 2) review existing strategies for minimizing patient-health risks through applied risk assessment; and 3) learn from experiences related to application in practice. Methodology: A semi-structured questionnaire focusing on medicine shortages was distributed electronically to members of the European Cooperation in Science and Technology (COST) Action 15105 (28 member countries) and to hospital pharmacists of the European Association of Hospital Pharmacists (EAHP) (including associated healthcare professionals). Their answers were subjected to both qualitative and quantitative analysis (Microsoft Office Excel 2010 and IBM SPSS Statistics®) with descriptive statistics based on the distribution of responses. Their proportional difference was tested by the chi-square test and Fisher's exact test for independence. Differences in the observed ordinal variables were tested by the Mann-Whitney or Kruskal-Wallis test. The qualitative data were tabulated and recombined with the quantitative data to observe, uncover and interpret meanings and patterns. Results: The participants (61.7%) are aware of the use of risk assessment procedures as a coping strategy for medicine shortages, and named the particular risk assessment procedure they are familiar with failure mode and effect analysis (FMEA) (26.4%), root cause analysis (RCA) (23.5%), the healthcare FMEA (HFMEA) (14.7%), and the hazard analysis and critical control point (HACCP) (14.7%). Only 29.4% report risk assessment as integrated into mitigation strategy protocols. Risk assessment is typically conducted within multidisciplinary teams (35.3%). Whereas 14.7% participants were aware of legislation stipulating risk assessment implementation in shortages, 88.2% claimed not to have reported their findings to their respective official institutions. 85.3% consider risk assessment a useful mitigation strategy. Conclusion: The study indicates a lack of systematically organized tools used to prospectively analyze clinical as well as operationalized risk stemming from medicine shortages in healthcare. There is also a lack of legal instruments and sufficient data confirming the necessity and usefulness of risk assessment in mitigating medicine shortages in Europe. © Copyright © 2020 Miljković, Godman, Kovačević, Polidori, Tzimis, Hoppe-Tichy, Saar, Antofie, Horvath, De Rijdt, Vida, Kkolou, Preece, Tubić, Peppard, Martinez, Yubero, Haddad, Rajinac, Zelić, Jenzer, Tartar, Gitler, Jeske, Davidescu, Beraud, Kuruc-Poje, Haag, Fischer, Sviestina, Ljubojević, Markestad, Vujić-Aleksić, Nežić, Crkvenčić, Linnolahti, Ašanin, Duborija-Kovačević, Bochenek, Huys and Miljković.
PB  - Frontiers Media S.A.
T2  - Frontiers in Pharmacology
T1  - Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications
VL  - 11
DO  - 10.3389/fphar.2020.00357
ER  - 

@article{
author = "Miljković, Nenad and Godman, Brian and Kovačević, Milena and Polidori, Piera and Tzimis, Leonidas and Hoppe-Tichy, Torsten and Saar, Marika and Antofie, Ioan and Horvath, Laszlo and De Rijdt, Thomas and Vida, Róbert György and Kkolou, Elena and Preece, David and Tubić, Biljana and Peppard, Joan and Martinez, Alicia and Yubero, Cristina Garcia and Haddad, Ratiba and Rajinac, Dragana and Zelić, Pavle and Jenzer, Helena and Tartar, Franci and Gitler, Gunda and Jeske, Martina and Davidescu, Michal and Beraud, Michal and Kuruc-Poje, Darija and Haag, Sakstrup Haag and Fischer, Hanne and Sviestina, Inese and Ljubojević, Gordana and Markestad, Anne and Vujić-Aleksić, Vesna and Nežić, Lana and Crkvenčić, Anica and Linnolahti, Johanna and Ašanin, Bogdan and Duborija-Kovačević, Nataša and Bochenek, Tomasz and Huys, Isabelle and Miljković, Branislava",
year = "2020",
abstract = "Introduction: While medicine shortages are complex, their mitigation is more of a challenge. Prospective risk assessment as a means to mitigate possible shortages, has yet to be applied equally across healthcare settings. The aims of this study have been to: 1) gain insight into risk-prevention against possible medicine shortages among healthcare experts; 2) review existing strategies for minimizing patient-health risks through applied risk assessment; and 3) learn from experiences related to application in practice. Methodology: A semi-structured questionnaire focusing on medicine shortages was distributed electronically to members of the European Cooperation in Science and Technology (COST) Action 15105 (28 member countries) and to hospital pharmacists of the European Association of Hospital Pharmacists (EAHP) (including associated healthcare professionals). Their answers were subjected to both qualitative and quantitative analysis (Microsoft Office Excel 2010 and IBM SPSS Statistics®) with descriptive statistics based on the distribution of responses. Their proportional difference was tested by the chi-square test and Fisher's exact test for independence. Differences in the observed ordinal variables were tested by the Mann-Whitney or Kruskal-Wallis test. The qualitative data were tabulated and recombined with the quantitative data to observe, uncover and interpret meanings and patterns. Results: The participants (61.7%) are aware of the use of risk assessment procedures as a coping strategy for medicine shortages, and named the particular risk assessment procedure they are familiar with failure mode and effect analysis (FMEA) (26.4%), root cause analysis (RCA) (23.5%), the healthcare FMEA (HFMEA) (14.7%), and the hazard analysis and critical control point (HACCP) (14.7%). Only 29.4% report risk assessment as integrated into mitigation strategy protocols. Risk assessment is typically conducted within multidisciplinary teams (35.3%). Whereas 14.7% participants were aware of legislation stipulating risk assessment implementation in shortages, 88.2% claimed not to have reported their findings to their respective official institutions. 85.3% consider risk assessment a useful mitigation strategy. Conclusion: The study indicates a lack of systematically organized tools used to prospectively analyze clinical as well as operationalized risk stemming from medicine shortages in healthcare. There is also a lack of legal instruments and sufficient data confirming the necessity and usefulness of risk assessment in mitigating medicine shortages in Europe. © Copyright © 2020 Miljković, Godman, Kovačević, Polidori, Tzimis, Hoppe-Tichy, Saar, Antofie, Horvath, De Rijdt, Vida, Kkolou, Preece, Tubić, Peppard, Martinez, Yubero, Haddad, Rajinac, Zelić, Jenzer, Tartar, Gitler, Jeske, Davidescu, Beraud, Kuruc-Poje, Haag, Fischer, Sviestina, Ljubojević, Markestad, Vujić-Aleksić, Nežić, Crkvenčić, Linnolahti, Ašanin, Duborija-Kovačević, Bochenek, Huys and Miljković.",
publisher = "Frontiers Media S.A.",
journal = "Frontiers in Pharmacology",
title = "Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications",
volume = "11",
doi = "10.3389/fphar.2020.00357"
}

Miljković, N., Godman, B., Kovačević, M., Polidori, P., Tzimis, L., Hoppe-Tichy, T., Saar, M., Antofie, I., Horvath, L., De Rijdt, T., Vida, R. G., Kkolou, E., Preece, D., Tubić, B., Peppard, J., Martinez, A., Yubero, C. G., Haddad, R., Rajinac, D., Zelić, P., Jenzer, H., Tartar, F., Gitler, G., Jeske, M., Davidescu, M., Beraud, M., Kuruc-Poje, D., Haag, S. H., Fischer, H., Sviestina, I., Ljubojević, G., Markestad, A., Vujić-Aleksić, V., Nežić, L., Crkvenčić, A., Linnolahti, J., Ašanin, B., Duborija-Kovačević, N., Bochenek, T., Huys, I.,& Miljković, B.. (2020). Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications. in Frontiers in Pharmacology
Frontiers Media S.A.., 11.
https://doi.org/10.3389/fphar.2020.00357

Miljković N, Godman B, Kovačević M, Polidori P, Tzimis L, Hoppe-Tichy T, Saar M, Antofie I, Horvath L, De Rijdt T, Vida RG, Kkolou E, Preece D, Tubić B, Peppard J, Martinez A, Yubero CG, Haddad R, Rajinac D, Zelić P, Jenzer H, Tartar F, Gitler G, Jeske M, Davidescu M, Beraud M, Kuruc-Poje D, Haag SH, Fischer H, Sviestina I, Ljubojević G, Markestad A, Vujić-Aleksić V, Nežić L, Crkvenčić A, Linnolahti J, Ašanin B, Duborija-Kovačević N, Bochenek T, Huys I, Miljković B. Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications. in Frontiers in Pharmacology. 2020;11.
doi:10.3389/fphar.2020.00357 .

Miljković, Nenad, Godman, Brian, Kovačević, Milena, Polidori, Piera, Tzimis, Leonidas, Hoppe-Tichy, Torsten, Saar, Marika, Antofie, Ioan, Horvath, Laszlo, De Rijdt, Thomas, Vida, Róbert György, Kkolou, Elena, Preece, David, Tubić, Biljana, Peppard, Joan, Martinez, Alicia, Yubero, Cristina Garcia, Haddad, Ratiba, Rajinac, Dragana, Zelić, Pavle, Jenzer, Helena, Tartar, Franci, Gitler, Gunda, Jeske, Martina, Davidescu, Michal, Beraud, Michal, Kuruc-Poje, Darija, Haag, Sakstrup Haag, Fischer, Hanne, Sviestina, Inese, Ljubojević, Gordana, Markestad, Anne, Vujić-Aleksić, Vesna, Nežić, Lana, Crkvenčić, Anica, Linnolahti, Johanna, Ašanin, Bogdan, Duborija-Kovačević, Nataša, Bochenek, Tomasz, Huys, Isabelle, Miljković, Branislava, "Prospective Risk Assessment of Medicine Shortages in Europe and Israel: Findings and Implications" in Frontiers in Pharmacology, 11 (2020),
https://doi.org/10.3389/fphar.2020.00357 . .

TY  - JOUR
AU  - Ljubojević, Gordana
AU  - Miljković, Branislava
AU  - Bucma, Tatjana
AU  - Ćulafić, Milica
AU  - Prostran, Milica
AU  - Vezmar-Kovačević, Sandra
PY  - 2017
UR  - https://farfar.pharmacy.bg.ac.rs/handle/123456789/2801
AB  - Background In the last 30 years, activities of hospital pharmacists have gone through significant changes. Pharmacists are increasingly involved in patient care. Objectives To explore drug-related and logistic problems, interventions, and their outcomes during routine everyday work of hospital pharmacists. Setting Institute for physical medicine and rehabilitation, Banja Luka, Bosnia and Herzegovina. Methods In the period of January 2013-October 2015 a prospective observational study was performed. Medical doctors, nurses, therapists, and patients addressed pharmacists, face-to-face or by telephone, with drug-related problems (DRPs) and/or logistic issues. Main outcome measure Type of DRP or logistic issue, intervention, outcome, initiator and time spent for solving the problem were documented for each consultation. Results Out of 1515 interventions, 48.8% were aimed at solving DRPs. The most common DRPs were the recommendation of a drug or dose and need for additional information about drugs. Drug price and supply were the most prevalent logistic issues. DRPs were more frequently initiated by medical doctors and required more time to solve the problem compared to logistic issues (Mann-Whitney U test, p  lt = 0.001, respectively). The acceptance rate of interventions to solve DRPs (83.7%) was lower compared to logistic issues (95.2%; p  lt = 0.001). Conclusions Hospital pharmacists were faced with an approximately equal number of DRPs and logistic issues during their routine everyday work. The overall acceptance rate of pharmacists' interventions was high, and the results of our study indicate that there is a need for more involvement of hospital pharmacists in Bosnia and Herzegovina in clinical activities. Impact on practice.
PB  - Springer, Dordrecht
T2  - International Journal of Clinical Pharmacy
T1  - Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina
VL  - 39
IS  - 4
SP  - 743
EP  - 749
DO  - 10.1007/s11096-017-0491-x
ER  - 

@article{
author = "Ljubojević, Gordana and Miljković, Branislava and Bucma, Tatjana and Ćulafić, Milica and Prostran, Milica and Vezmar-Kovačević, Sandra",
year = "2017",
abstract = "Background In the last 30 years, activities of hospital pharmacists have gone through significant changes. Pharmacists are increasingly involved in patient care. Objectives To explore drug-related and logistic problems, interventions, and their outcomes during routine everyday work of hospital pharmacists. Setting Institute for physical medicine and rehabilitation, Banja Luka, Bosnia and Herzegovina. Methods In the period of January 2013-October 2015 a prospective observational study was performed. Medical doctors, nurses, therapists, and patients addressed pharmacists, face-to-face or by telephone, with drug-related problems (DRPs) and/or logistic issues. Main outcome measure Type of DRP or logistic issue, intervention, outcome, initiator and time spent for solving the problem were documented for each consultation. Results Out of 1515 interventions, 48.8% were aimed at solving DRPs. The most common DRPs were the recommendation of a drug or dose and need for additional information about drugs. Drug price and supply were the most prevalent logistic issues. DRPs were more frequently initiated by medical doctors and required more time to solve the problem compared to logistic issues (Mann-Whitney U test, p  lt = 0.001, respectively). The acceptance rate of interventions to solve DRPs (83.7%) was lower compared to logistic issues (95.2%; p  lt = 0.001). Conclusions Hospital pharmacists were faced with an approximately equal number of DRPs and logistic issues during their routine everyday work. The overall acceptance rate of pharmacists' interventions was high, and the results of our study indicate that there is a need for more involvement of hospital pharmacists in Bosnia and Herzegovina in clinical activities. Impact on practice.",
publisher = "Springer, Dordrecht",
journal = "International Journal of Clinical Pharmacy",
title = "Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina",
volume = "39",
number = "4",
pages = "743-749",
doi = "10.1007/s11096-017-0491-x"
}

Ljubojević, G., Miljković, B., Bucma, T., Ćulafić, M., Prostran, M.,& Vezmar-Kovačević, S.. (2017). Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina. in International Journal of Clinical Pharmacy
Springer, Dordrecht., 39(4), 743-749.
https://doi.org/10.1007/s11096-017-0491-x

Ljubojević G, Miljković B, Bucma T, Ćulafić M, Prostran M, Vezmar-Kovačević S. Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina. in International Journal of Clinical Pharmacy. 2017;39(4):743-749.
doi:10.1007/s11096-017-0491-x .

Ljubojević, Gordana, Miljković, Branislava, Bucma, Tatjana, Ćulafić, Milica, Prostran, Milica, Vezmar-Kovačević, Sandra, "Problems, interventions, and their outcomes during the routine work of hospital pharmacists in Bosnia and Herzegovina" in International Journal of Clinical Pharmacy, 39, no. 4 (2017):743-749,
https://doi.org/10.1007/s11096-017-0491-x . .